Welcome to our dedicated page for Colgate Palmolive Co news (Ticker: CL), a resource for investors and traders seeking the latest updates and insights on Colgate Palmolive Co stock.
Colgate-Palmolive Company (CL) generates news across multiple categories reflecting its position as one of the world's largest consumer products manufacturers. The company's news flow typically includes quarterly earnings releases detailing performance across its oral care, personal care, home care, and pet nutrition segments, along with dividend announcements reflecting its multi-decade track record of consecutive dividend increases. Product launches and brand innovations drive consumer-focused announcements, while investor presentations at major conferences provide management commentary on strategic priorities and market trends.
Key news categories for Colgate-Palmolive include financial performance updates that reveal geographic segment trends across North America, Latin America, Europe, and Asia-Pacific markets. The company's oral care division often generates product innovation announcements as the segment maintains global market leadership in toothpaste and related categories. Pet nutrition news under the Hill's brand includes new formulations for Science Diet and Prescription Diet lines, targeting premium pet food markets. Dividend declarations occur quarterly, reflecting the company's capital allocation priorities and appeal to income-focused investors.
This news feed provides real-time coverage of Colgate-Palmolive developments, including earnings conference call schedules, investor presentation webcasts, regulatory filings, and corporate announcements. Following Colgate news helps investors track performance across diverse international markets, understand consumer trends in oral care and household products, and monitor the company's competitive positioning against major rivals in the fast-moving consumer goods sector. Bookmark this page to stay informed about one of the most established dividend-paying consumer staples companies in the global market.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) has opened its tenth dispensary in Illinois, located in Naperville, a key retail area near major stores like Costco and Whole Foods. This marks a significant milestone as Cresco becomes the first cannabis operator to reach ten dispensaries in the state. The Sunnyside Naperville dispensary spans nearly 8,400 square feet and will employ approximately 40 staff, featuring 12 points of sale. Illinois cannabis retail sales are projected at over $1 billion annually, with Cresco's stores capturing a substantial market share.
Cresco Labs (CSE:CL) (OTCQX:CRLBF), a major cannabis operator in the U.S., has extended its distribution agreement with Kings Garden Inc., a leading California cannabis brand. This agreement allows Cresco's subsidiary, Continuum, to continue as the exclusive distributor of Kings Garden products, enhancing their market presence. Kings Garden is recognized for its premium cannabis products and strong sales performance. The partnership is expected to boost growth and market share for both companies in California, one of Cresco's key markets.
Cresco Labs (CSE:CL, OTCQX:CRLBF) expands its Good News brand to Michigan, tapping into a rapidly growing cannabis market worth nearly $600 million. The launch features gummy edibles crafted for different moods — Me Time (Indica), Brunch (Hybrid), Friyay (Sativa), and Vegas (Sativa). Michigan, now the tenth state to legalize adult-use cannabis, generated over $104 million in sales in October alone. This expansion adds to Cresco’s portfolio, which includes brands like Mindy’s and High Supply, enhancing product variety for both medical and recreational consumers.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) has finalized an agreement with lenders to extend the maturity of its senior secured term loan to January 23, 2023, with a reduced interest rate of 12% annually. The loan size will increase to $200 million, with $85 million from existing and new institutional lenders. This funding aims to support Cresco's expansions across nine states and other growth initiatives. CEO Charlie Bachtell emphasized the positive implications of this financing in enhancing the company’s operational flexibility and capital efficiency.
Colgate's recent research indicates that its toothpastes containing zinc and stannous, along with mouthwashes with cetylpyridinium chloride, can neutralize COVID-19 by 99.9%. Laboratory studies showed Colgate Total and Meridol toothpastes had this effect after two minutes, while Colgate mouthwashes were effective after just 30 seconds. A clinical study involving 50 hospitalized COVID-19 patients is underway, revealing these products can temporarily reduce viral load in the mouth. Colgate is collaborating on further research to explore potential roles of oral care in reducing COVID-19 transmission.
Colgate-Palmolive (NYSE:CL) Group President Panagiotis Tsourapas will engage in a virtual fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 2, 2020, at 11:00 a.m. ET. Investors can access the live webcast on Colgate's website, and a recorded version will be available later. Colgate-Palmolive focuses on health-related products across various sectors, aiming for sustainable growth and superior shareholder returns. For further details about their initiatives, visit www.colgatepalmolive.com.
Colgate-Palmolive Company (NYSE:CL) announced the appointment of Stanley J. Sutula as the new Chief Financial Officer, effective November 9, 2020. Sutula, currently serving as CFO at Pitney Bowes, brings extensive experience from his previous 28 years at IBM. He is recognized for leveraging technology and data analytics to drive revenue growth. Henning Jakobsen, the outgoing CFO, will transition to a Senior Vice President role until his retirement at the end of 2020. The leadership change aims to strengthen Colgate's financial strategies and performance.
Colgate-Palmolive Company (NYSE:CL) reported robust third quarter results for 2020, with net sales rising by 5.5% to $4,153 million and organic sales up 7.5%. GAAP EPS increased 21% to $0.81, while Base Business EPS rose 11% to $0.79. Gross profit margin improved by 220 basis points to 61.2%. Market leadership was maintained in toothpaste (39.9% share) and manual toothbrushes (31.1% share). The company expects full-year sales to rise by mid-single digits, alongside earnings growth. Enhanced advertising investments and premium innovations are driving the positive momentum.